Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic myeloablative transplantation for patients aged 50 years and over.
Yanada M, Emi N, Naoe T, Sakamaki H, Iseki T, Hirabayashi N, Karasuno T, Chiba S, Atsuta Y, Hamajima N, Takahashi S, Kato S. Yanada M, et al. Among authors: kato s. Bone Marrow Transplant. 2004 Jul;34(1):29-35. doi: 10.1038/sj.bmt.1704518. Bone Marrow Transplant. 2004. PMID: 15156161
Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M, Emi N, Naoe T, Sakamaki H, Takahashi S, Hirabayashi N, Hiraoka A, Kanda Y, Tanosaki R, Okamoto S, Iwato K, Atsuta Y, Hamajima N, Tanimoto M, Kato S. Yanada M, et al. Among authors: kato s. Bone Marrow Transplant. 2004 Aug;34(4):331-7. doi: 10.1038/sj.bmt.1704596. Bone Marrow Transplant. 2004. PMID: 15220958
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F. Kodera Y, et al. Among authors: kato s. Bone Marrow Transplant. 1999 Nov;24(9):995-1003. doi: 10.1038/sj.bmt.1702027. Bone Marrow Transplant. 1999. PMID: 10556959
Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S, Nakao S, Ueda M, Yamazaki H, Takahashi S, Asano S, Yabe H, Kato S, Imoto S, Maruta A, Yoshida T, Gondo H, Morishima Y, Kodera Y. Shiobara S, et al. Among authors: kato s. Bone Marrow Transplant. 2000 Oct;26(7):769-74. doi: 10.1038/sj.bmt.1702596. Bone Marrow Transplant. 2000. PMID: 11042659
Cardiovascular toxicity of cryopreserved cord blood cell infusion.
Konuma T, Ooi J, Takahashi S, Tomonari A, Tsukada N, Kobayashi T, Sato A, Kato S, Kasahara S, Ebihara Y, Nagamura-Inoue T, Tsuji K, Tojo A, Asano S. Konuma T, et al. Among authors: kato s. Bone Marrow Transplant. 2008 May;41(10):861-5. doi: 10.1038/sj.bmt.1705993. Epub 2008 Jan 21. Bone Marrow Transplant. 2008. PMID: 18209718
7,154 results